Uncontrolled studies of CBD-rich cannabis extracts showed improvements in autism-related symptoms, but placebo-controlled trials have produced mixed results, and researchers recommend waiting for ongoing trials before adopting CBD for ASD.
Parents of children with ASD exploring cannabinoid options, pediatric neurologists, clinical trial researchers
Mixed results in placebo-controlled trials
What the researchers found
Uncontrolled case series documented improvements in both core ASD symptoms and behavioral challenges with CBD-rich cannabis extracts. However, placebo-controlled studies of CBD-rich extracts and pure CBD showed mixed efficacy results. Studies demonstrated relatively high safety and tolerability.
Why it matters
ASD affects approximately 3% of school-age children with no approved treatment for core symptoms. Current medications (risperidone, aripiprazole) only address irritability with limited effectiveness and common side effects. Families increasingly seek cannabinoid alternatives.
The numbers in context
ASD affects ~3% of school-age children. Only risperidone and aripiprazole are approved for ASD-related irritability. Placebo-controlled studies included CBD-rich cannabis extracts, pure CBD, and studies in Fragile X syndrome.
How the study worked
Mini-review summarizing existing literature and ongoing clinical trials of cannabinoid treatments for ASD, including uncontrolled case series and placebo-controlled studies of CBD-rich extracts and pure CBD.
What this study cannot tell us
Uncontrolled studies are susceptible to placebo and expectancy effects, particularly in behavioral conditions. Placebo-controlled trials are few and showed mixed results. Different formulations (pure CBD vs. CBD-rich extracts) may have different effects.
How to read the evidence
Mini-review of limited clinical trial evidence, with uncontrolled studies showing benefits but placebo-controlled trials producing mixed results.
When this study was published
2024 review of cannabinoid treatment evidence for ASD
The bigger picture
The gap between parental enthusiasm for CBD in ASD and the mixed clinical evidence mirrors patterns seen with other conditions where traditional treatments fall short. The relatively good safety profile may justify continued investigation even without proven efficacy.
Questions still open
- Will ongoing placebo-controlled trials clarify whether CBD benefits core ASD symptoms? Does CBD-rich whole-plant extract work differently than pure CBD for ASD?
Common questions
Is CBD approved for treating autism?
Is CBD safe for children with autism?
Read the original research
Cannabinoid treatment for the symptoms of autism spectrum disorder.
Expert opinion on emerging drugs, 29(1), 65-79
Citation
Aran, Adi; Cayam Rand, Dalit. (2024). Cannabinoid treatment for the symptoms of autism spectrum disorder.. Expert opinion on emerging drugs, 29(1), 65-79. https://doi.org/10.1080/14728214.2024.2306290
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk